To subscribe:
To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.
(4 votes, average: 4.00 out of 5)
(3 votes, average: 2.33 out of 5)
(1 votes, average: 3.00 out of 5)I tried arranging an interview across a 13-hour time difference, with no luck. We revisit, instead, an October conversation about the late clinical course of dementia. First a look at the news. Comments to jelia@jwatch.org or to 1-617-440-4374. Interview link: Advanced Dementia’s Course News links: Massachusetts elects a U.S. Senator Screening and treating children for [...]
(2 votes, average: 3.00 out of 5)We talk with Susan Mitchell, a Harvard researcher who set out to characterize the final clinical stages of advanced dementia. There are some surprises — namely, the benefit of clear communications with patients and their families (which, come to think of it, shouldn’t come as much of a surprise at all). Talk with us at [...]
(5 votes, average: 4.60 out of 5)Northwestern’s Martha Gulati has just published a paper in Archives of Internal Medicine about the hazards of treating symptomatic women with normal angiograms as if they had a benign prognosis. We’ll talk with her after a look at the news, and a reminder that you can really help Clinical Conversations with your feedback. The place [...]
(1 votes, average: 4.00 out of 5)Neurologists have talked about these effects for a while, but now they’ve got evidence showing that valproate lowers IQ at age 3 by almost 10 points. Since only half the antiepileptics are used in epilepsy, the results will affect everyone caring for women of reproductive age. Kimford Meador of Emory University is here to talk [...]
